BRIEF published on 10/30/2024 at 08:05, 24 days 1 hour ago Syngenta Group Reports Q3 2024 Results Syngenta Group EBITDA Growth Sales Performance Q3 2024 Results Market Outlook 2025
PRESS RELEASE published on 10/30/2024 at 08:00, 24 days 1 hour ago Syngenta Group Reports Q3 2024 Results Syngenta Group reports Q3 2024 results with $6.8 billion in sales and $0.7 billion EBITDA, showing growth in China but challenges in Argentina. Focus on efficiency, innovation, and expecting EBITDA improvements in Q4 2024 China Sales Growth Argentina Syngenta Group Q3 2024 Results
BRIEF published on 10/25/2024 at 09:05, 29 days ago Syngenta Group Achieves Top Agricultural Employer Status for 8th Year Innovation Sustainability Technology Syngenta Group Agricultural Employer
PRESS RELEASE published on 10/25/2024 at 09:00, 29 days ago Syngenta Group is Science Magazine’s top agriculture employer for 8th year Syngenta Group named top agriculture employer by Science Magazine for 8th consecutive year, maintaining global rank. Focus on innovation and sustainability in agriculture sector Innovation Sustainability Syngenta Group Agriculture Employer Science Magazine
BRIEF published on 09/30/2024 at 08:05, 1 month 23 days ago Syngenta Group Introduces Cropwise AI at World AgriTech Summit Sustainability Machine Learning Syngenta Group Agricultural Innovation Cropwise AI
PRESS RELEASE published on 09/30/2024 at 08:00, 1 month 23 days ago Syngenta Group adds Cutting-Edge Generative Artificial Intelligence (GenAI) to Cropwise Syngenta Group launches Cropwise AI, a cutting-edge GenAI system for optimizing crop management practices with deep insights and enhanced decision-making capabilities Innovation Agriculture GenAI Syngenta Group Cropwise AI
BRIEF published on 08/29/2024 at 08:05, 2 months 25 days ago Syngenta Group Announces H1 2024 Earnings Operational Efficiency Market Conditions Agricultural Sector H1 2024 Results Syngenta Earnings
PRESS RELEASE published on 08/29/2024 at 08:00, 2 months 25 days ago Syngenta Group Reports H1 2024 Earnings Syngenta Group reports H1 2024 earnings with sales at $14.5 billion, down 17% from last year. Focus on operational efficiency and R&D for long-term growth Sales R&D Earnings Syngenta Group H1 2024
BRIEF published on 06/04/2024 at 09:05, 5 months 19 days ago Syngenta Opens Rights to Genome-Editing and Breeding Technologies to Boost Agricultural Innovation Sustainability Syngenta Agricultural Innovation CRISPR Genome-editing
PRESS RELEASE published on 06/04/2024 at 09:00, 5 months 19 days ago Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation Syngenta Group opens rights to genome-editing and breeding technologies for academic research globally to drive sustainability in agriculture Syngenta Group Agricultural Innovation CRISPR Genome-editing Breeding Technologies
Published on 11/22/2024 at 23:55, 9 hours 30 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 55 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 20 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 55 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 32 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 30 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 25 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
